All news (page 25)

• 

  19 February 2026

  Carbon Neutral Fuels Chooses Johnson Matthey, Honeywell for UK E-Fuels Project

  Project Starling will convert CO2 and water into sustainable aviation fuel, aiming for 25,000 tons annually by 2031, using advanced technologies for significant emissions savings.
• 

  19 February 2026

  Johnson & Johnson's Rybrevant Faspro™ Shows 56% Response Rate in First-Line Head and Neck Cancer

  The OrigAMI-4 study shows amivantamab with immunotherapy offers durable antitumor activity in recurrent/metastatic head and neck cancer, improving outcomes over current treatments.
• 

  19 February 2026

  Ercros Board Rejects Bondalti Takeover Bid

  The board cites strategic misalignment, potential debt increase, and shareholder opposition as reasons for rejecting the unsolicited bid.
• 

  19 February 2026

  Takeda's Phase 3 Study on Pediatric Ulcerative Colitis

  Vedolizumab shows promise in treating pediatric ulcerative colitis, achieving 47.3% remission at 54 weeks, with a safety profile consistent with adult use.
• 

  19 February 2026

  Toray's Ultrasuede™ Chosen by Case Furniture

  Ultrasuede™ is used in Case's Ella Lounge and 675 Chair, enhancing sustainability and design. Toray expands its European presence with a new showroom in Portugal.
• 

  19 February 2026

  BASF Introduces Circalo for Low Carbon Ethanol Production

  Circalo connects farmers and ethanol producers to reduce carbon intensity, aligning with Section 45Z, using xarvio tools for data verification and compliance.

• 

  19 February 2026

  Trinseo's Rho Plant Achieves ISO 9001 Certification

  The Rho facility's ISO 9001:2015 certification highlights its quality management and ability to produce high-quality recycled monomers. Other Trinseo sites also hold this certification.
• 

  19 February 2026

  BASF Launches AdBlue GE Using 100% Green Electricity

  AdBlue GE is made with renewable electricity, reducing CO2 emissions. It matches conventional AdBlue in quality and performance. Initial launch in Switzerland, with plans for wider European rollout.
• 

  19 February 2026

  Repsol Reports €2.568 Billion Adjusted Net Income

  Net income rose 8.1% to €1.899B in 2025. Adjusted net income fell 15.1% amid market volatility and geopolitical issues. Resilient performance supports strategic goals.
• 

  19 February 2026

  TechnipFMC Q4 2025 Financial Results

  Subsea orders hit $2.3B in Q4; full-year orders $10.1B. Shareholder distributions $188M in Q4, $1B annually. Revenue $2.5B, net income $242.7M, adjusted EBITDA $440.5M, margin 17.5%.
• 

  19 February 2026

  Statkraft's Former Employees Advance Biofuel Tech at Tofte

  Statkraft shifts focus to core technologies, transferring biofuel expertise to a new company led by former employees, aiming to commercialize HTL technology for emissions reduction.
• 

  19 February 2026

  Merck Reports Positive Phase 3 Trial Results for ENFLONSIA in High-Risk Infants and Children

  ENFLONSIA shows consistent safety and efficacy in high-risk infants over two RSV seasons, supporting expanded use for children under 2.
• 

  19 February 2026

  BENEO Names Dr Uwe Boltersdorf as COO

  Dr Uwe Boltersdorf, with 20+ years in management, becomes COO, overseeing operations, production, and sustainability, while retaining his role at CropEnergies AG.
• 

  19 February 2026

  INEOS Secures €300M French Grant to Decarbonise Lavera Site

  The investment cuts CO2 by 331,000 tonnes annually, secures jobs, boosts competitiveness, and supports France's industrial and climate goals through electrification and carbon capture.
• 

  19 February 2026

  AGC Biologics Gains Anvisa GMP Certification for Seattle Facility

  The Seattle site can now supply biopharmaceuticals to Brazil, enhancing AGC's global supply capabilities and expanding regulatory approvals to over 11 countries.
• 

  19 February 2026

  ORLEN Group Reports Strong 2025 with Record Investments

  In Q4 2025, LIFO-based EBITDA hit PLN 12.2B. Annual EBITDA reached PLN 41.9B, net profit PLN 11.2B. Investments of PLN 32.6B focused on energy security and low-carbon sources.
• 

  19 February 2026

  Asahi Kasei Pharma Partners with MAIA for U.S. Teribone™ Development

  MAIA will develop and commercialize Teribone™ in the U.S. to address the growing osteoporosis patient population, expanding access to proven bone-forming therapy.
• 

  19 February 2026

  Asahi Kasei's Thin-Film Hall Elements Earn IEEE Milestone Recognition

  Thin-film Hall elements, launched in 1983, revolutionized magnetic sensors, enhancing electronics and energy efficiency, with over 50 billion units shipped globally.
• 

  18 February 2026

  Asahi Kasei Pharma and Alchemedicine: AK1960 enters Phase I for refractory diseases

  AK1960, a novel ETA receptor antagonist with a new core structure, shows high ETA selectivity and kidney-disease efficacy in animals and has advanced to Phase I for refractory diseases.
• 

  18 February 2026

  AFC Energy Gains Approval to Export and Sell Low Carbon Hydrogen from Ammonia Cracking Plant

  The UK Environment Agency's permit revision allows hydrogen production training at Dunsfold and supports future deployments with Industrial Chemicals Group Ltd.
• 

  18 February 2026

  Asahi Kasei Pharma Advances AK1960 to Phase I for Refractory Diseases

  AK1960, an ETA receptor antagonist, enters Phase I trials for refractory diseases, leveraging Alchemedicine's HiSAP™ platform and partnerships with Calliditas and Veloxis.
• 

  18 February 2026

  Toray's Ehime and Nagoya Plants Achieve ISCC PLUS Certification for Engineering Plastics

  Two plants gain ISCC PLUS certification, enabling use of biomass and recycled materials in PBT and LCP resins, supporting carbon footprint reduction.
• 

  18 February 2026

  Iberdrola Named Most Sustainable Electricity Company for Seventh Year

  Ranked 17th in Clean200, Iberdrola excels in sustainability, energy security, and competitiveness, outperforming fossil fuel firms and earning top ESG ratings.
• 

  18 February 2026

  Johnson & Johnson Invests $1 Billion in Pennsylvania Cell Therapy Facility

  The new facility in Montgomery County will boost U.S. manufacturing capacity for cancer, immune-mediated, and neurological disease treatments.
• 

  18 February 2026

  Johnson & Johnson's RYBREVANT FASPRO™ Gains FDA Breakthrough Status for Advanced Head and Neck Cancer

  FDA grants Breakthrough Therapy Designation to RYBREVANT FASPRO™ for HPV-unrelated head and neck cancer after platinum-based chemotherapy and PD-1/PD-L1 inhibitor.
• 

  18 February 2026

  PureCycle and TOPPAN Partner for Sustainable Recycled Packaging Solutions

  They developed a snack bar wrapper with 30% recycled content, targeting thermoforming applications to meet regulatory demands without compromising safety or performance.
• 

  18 February 2026

  Merck and Mayo Clinic Collaborate on AI-Driven Drug Discovery

  The collaboration combines clinical data and AI to enhance drug discovery, focusing on gastroenterology, dermatology, and neurology for tailored therapies.
• 

  18 February 2026

  Baltic Power Completes Foundation Installation for Offshore Wind Farm

  All 78 monopile foundations are installed at Poland's first offshore wind farm, with electricity set to be supplied by year-end. Construction completion is expected in late 2026.
• 

  18 February 2026

  Lilly's Taltz and Zepbound Show Superior Results in Psoriasis and Obesity Trial

  Taltz and Zepbound together improved skin clearance and weight loss in psoriasis patients with obesity, outperforming Taltz alone in a Phase 3b trial.
• 

  18 February 2026

  VolagHy Releases EIA Program for Kuopio Site

  The EIA program for the Kuopio site outlines environmental, social, and land-use assessments, moving the project into the formal evaluation phase with stakeholder engagement.